Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Krka Makes Small Investment in Two China Pharmas

publication date: Jun 26, 2008

Krka, the large generic pharmaceutical company based in Ljubljana, Slovenia, bought a small stake in two China pharmaceutical companies. According to the company, the move will secure a source for inexpensive APIs and chemicals for Krka’s generic drugs. Krka paid just under $800,000 for a 7.5% share of Cejang Menovo Pharmaceuticals Co. Ltd. and Anhui Menovo Pharmaceuticals Co. Ltd. Together, the two companies have total annual revenues of approximately $30 million. More details...



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital